References

  1. Greenwood B. Manson Lecture: Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):341-53. PubMed | Google Scholar

  2. Marc LaForce F, Ravenscroft N, Djingarey M, Viviani S. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution. Vaccine. 2009 Jun 24;27(Suppl 2):B13-9. PubMed | Google Scholar

  3. World Health organization. Meningococcal disease control in countries of the African meningitis belt, 201 Wkly Epidemiol Rec. 2014 May 16;89(20):206-14. PubMed | Google Scholar

  4. Frasch CE, Preziosi MP, LaForce FM. Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM). Hum Vaccin Immunother. 2012 Jun;8(6):715-24. PubMed | Google Scholar

  5. Djingarey MH, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D et al. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine. 2012 May 30;30(Suppl 2):B40-5. PubMed | Google Scholar

  6. Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, Carlone G et al. Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med. 2011 Jun 16;364(24):2293-304. PubMed | Google Scholar

  7. Techathawat S, Varinsathien P, Rasdjarmrearnsook A, Tharmaphornpilas P. Exposure to heat and freezing in the vaccine cold chain in Thailand. Vaccine. 2007 Jan 26;25(7):1328-33. PubMed | Google Scholar

  8. Schondorf I, Banzhoff A, Nicolay U, Diaz-Mitoma F. Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: A controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate, stored at room temperature for 6 months. Vaccine. 2007 Jan 26;25(7):1175-82. PubMed | Google Scholar

  9. Le Tallec D, Doucet D, Elouahabi A, Harvengt P, Deschuyteneer M, Deschamps M. Cervarix, the GSK HPV-16/HPV-18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions. Hum Vaccin. 2009 Jul;5(7):467-74. PubMed | Google Scholar

  10. Chen D, Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines. 2009 May;8(5):547-57. PubMed | Google Scholar

  11. Organisation Mondiale de la Santé. Utilisation du MenAfriVacTM (vaccin contre la méningite A) en chaîne à température contrôlée (CTC) pendant les campagnes. Genève OMS; 2014. Google Scholar

  12. Ministère de la Santé du Togo. Rapport de la mise en œuvre de la campagne de vaccination contre la méningite avec le MenAfriVac au Togo en 2014. Lomé, Division de l'Epidémiologie. 2015. Google Scholar

  13. Direction Générale de la Statistique et de la Comptabilité Nationale (DGSCN). Recensement Général de la Population. Lomé: DGSCN. 2010. PubMed | Google Scholar

  14. Centers for Disease Control and Prevention. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011. MMWR Morb Mortal Wkly Rep. 2012 Dec 21;61(50):1022-4. PubMed | Google Scholar

  15. Kristiansen PA, Jorgensen HJ, Caugant DA. Serogroup A meningococcal conjugate vaccines in Africa. Expert Rev Vaccines. 2015;14(11):1441-58. PubMed | Google Scholar

  16. Trotter CL, Cibrelus L, Fernandez K, Lingani C, Ronveaux O, Stuart JM. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac(R). Vaccine. 2015 Nov 17;33(46):6212-7. PubMed | Google Scholar

  17. Zipursky S, Djingarey MH, Lodjo JC, Olodo L, Tiendrebeogo S, Ronveaux O. Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin. Vaccine. 2014 Mar 14;32(13):1431-5. PubMed | Google Scholar

  18. Steffen C, Tokplonou E, Jaillard P, Dia R, Alladji MN, Gessner B. A field based evaluation of adverse events following MenAfriVac(R) vaccine delivered in a controlled temperature chain (CTC) approach in Benin. Pan Afr Med J. 2014;18:344. PubMed | Google Scholar

  19. Landoh DE, Ouro-Kavalah F, Yaya I, Kahn AL, Wasswa P, Lacle A et al. Predictors of incomplete immunization coverage among one to five years old children in Togo. BMC Public Health. 2016 Sep 13;16:968. PubMed | Google Scholar